期刊文献+

Effect of TRAF6 gene silencing on hepatocellular carcinoma cell line SMCC7721 and its possible mechanism

下载PDF
导出
摘要 Objective:To explore the effect of TRAF6 gene silencing on the function of hepatocellular carcinoma SMCC7721 and its possible mechanism.Method:Cell lines were constructed by cell transfection technology and verified by quantitative real-time PCR.Cell functional changes were observed by CCK8 method,Transwell test and Method of EdU.Western blotting was used to explore the possible mechanism of action.Result:TRAF6 RNA was abnormally up-regulated in HCC,and TRAF6 levels were detected in both HCC cell lines and L02 cells.SMCC7721 was selected as TRAF6 high expression cell.The results of CCK8 assay and EdU method showed that the decrease of TRAF6 expression significantly inhibited the proliferation of SMCC7721 cells.The results of CCK8 assay and EdU method showed that the decrease of TRAF6 expression significantly inhibited the proliferation of SMCC7721 cells.Overexpression of TRAF6 in TRAF6 knockdown cells can restore and enhance cell proliferation.Transwell assay confirmed that the invasiveness of SMCC 7721 cells treated with siRNA was significantly reduced.After treatment with LV-Rescue plasmid,the cell invasion was restored and enhanced.Western blotting showed that the protein levels of YB-1,Wnt,β-catenin,c-myc and Cyclin D1 were significantly down-regulated in siRNA group.On the contrary,the expression level of CYLD protein increased.Conclusion:As an important intracellular junctive protein in tumor cells,TRAF6 may improve the expression of pro-cancer factors C-myc and Cyclin D1 by modifying(ubiquitination)YB-1,thus improving the proliferation ability of cells.This process may be closely positively correlated with the Wnt/β-catenin pathway,and negatively correlated with the expression of CYLD protein.
出处 《Journal of Hainan Medical University》 2022年第2期23-27,共5页 海南医学院学报(英文版)
基金 Scientific Research Project of Health and Family Planning Commission of Nantong(No.MB2020007 QA 2019004)。
  • 相关文献

参考文献1

二级参考文献76

  • 1Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma.Lancet 2003; 362: 1907-1917 [PMID: 14667750 DOI: 10.1016/S0140-6736(03)14964-1]. 被引量:1
  • 2El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011; 365:1118-1127 [PMID: 21992124 DOI: 10.1056/NEJMra1001683]. 被引量:1
  • 3Llovet JM, Bruix J. Molecular targeted therapies in hepatocellularcarcinoma. Hepatology 2008; 48: 1312-1327 [PMID: 18821591DOI: 10.1002/hep.22506]. 被引量:1
  • 4Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF,de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, PortaC, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, BorbathI, Haussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D,Bruix J. Sorafenib in advanced hepatocellular carcinoma. N EnglJ Med 2008; 359: 378-390 [PMID: 18650514 DOI: 10.1056/NEJMoa0708857]. 被引量:1
  • 5Kudo M. Current status of molecularly targeted therapy forhepatocellular carcinoma: clinical practice. Int J Clin Oncol 2010;15: 242-255 [PMID: 20509038 DOI: 10.1007/s10147-010-0089-y]. 被引量:1
  • 6Laurent-Puig P, Zucman-Rossi J. Genetics of hepatocellulartumors. Oncogene 2006; 25: 3778-3786 [PMID: 16799619 DOI:10.1038/sj.onc.1209547]. 被引量:1
  • 7Nejak-Bowen KN, Monga SP. Beta-catenin signaling, liverregeneration and hepatocellular cancer: sorting the good from thebad. Semin Cancer Biol 2011; 21: 44-58 [PMID: 21182948 DOI:10.1016/j.semcancer.2010.12.010]. 被引量:1
  • 8Clevers H, Nusse R. Wnt/兝-catenin signaling and disease. Cell 2012;149: 1192-1205 [PMID: 22682243 DOI: 10.1016/j.cell.2012.05.012]. 被引量:1
  • 9Lee HC, Kim M, Wands JR. Wnt/Frizzled signaling inhepatocellular carcinoma. Front Biosci 2006; 11: 1901-1915[PMID: 16368566]. 被引量:1
  • 10Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wntsignaling in cancer. Biochim Biophys Acta 2003; 1653: 1-24 [PMID:12781368]. 被引量:1

共引文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部